1902 - Impact of treatment with ibrutinib or venetoclax on CAR-T cell generation in patients with chronic lymphocytic leukemia. Interim analysis of the GIMEMA CLL2020 study

Primary Author / Presenter(s)

MC

Marta Coscia, MD, PhD

Director, Division of Hematology, ASST Sette Laghi, Varese, italy
Department of Medicine and Surgery, University of Insubria and Department of Oncology, ASST Sette Laghi, Ospedale di Circolo e Fondazione Macchi
Varese, Lombardia, Italy

Co-Author(s)

RJ

Rebecca Jones, MS

Research fellow
Division of Hematology, A.O.U. Città della Salute e della Scienza di Torino, Turin; Department of Molecular Biotechnology and Health Sciences, University of Torino
Torino, Piemonte, Italy
VG

Valentina Griggio, PhD

Post Doc fellow
Division of Hematology, A.O.U. Città della Salute e della Scienza di Torino, Turin; Department of Molecular Biotechnology and Health Sciences, University of Torino
Torino, Piemonte, Italy
AP

Alfonso Piciocchi

GIMEMA Foundation
Roma, Lazio, Italy
GM

Giorgia Mancin, MS

Division of Hematology, A.O.U. Città della Salute e della Scienza di Torino, Turin; Department of Molecular Biotechnology and Health Sciences, University of Torino
Torino, Piemonte, Italy
VS

Valeria Sargentini

GIMEMA Foundation
Roma, Lazio, Italy
FP

Francesca Perutelli, MD

Division of Hematology
Department of Molecular Biotechnology and Health Sciences, University of Torino & University Division of Hematology, A.O.U. Città della Salute e della Scienza di Torino
Torino, Piemonte, Italy
MM

Maria Chiara Montalbano

Division of Hematology, A.O.U. Città della Salute e della Scienza di Torino, Turin; Department of Molecular Biotechnology and Health Sciences, University of Torino
Torino, Piemonte, Italy
GO

Giacomo Ortone, MD

Division of Hematology, A.O.U. Città della Salute e della Scienza di Torino, Turin; Department of Molecular Biotechnology and Health Sciences, University of Torino
Torino, Piemonte, Italy
Riccardo Moia, MD, PhD

Postdoctoral Fellow
Division of Hematology, Department of Translational Medicine, Università del Piemonte Orientale, Novara
Novara, Piemonte, Italy
AB

Alessandro Bosi

Hematology Unit, Fondazione IRCCS Ca' Granda Policlinico
Milano, Lombardia, Italy
Lydia Scarfò

Assistant Professor
Università Vita Salute and IRCCS Ospedale San Raffaele
Milano, Lombardia, Italy
Paolo Ghia, MD, PhD

Professor of Medical Oncology
Università Vita Salute and IRCCS Ospedale San Raffaele
Milano, Lombardia, Italy
FP

Francesco Passamonti

Hematology Unit, Fondazione IRCCS Ca' Granda Policlinico
Milano, Lombardia, Italy
Gianluca Gaidano, MD, PhD

Professor of Hematology
University of Eastern Piedmont, Maggiore Charity Hospital
Novara, Italy
RF

Robin Foà

Hematology, Department of Translational and Precision Medicine, Sapienza University
Rome, Lazio, Italy
BB

Benedetto Bruno, MD, PhD

Division of Hematology, A.O.U. Città della Salute e della Scienza di Torino, Turin; Department of Molecular Biotechnology and Health Sciences, University of Torino
Torino, Piemonte, Italy
CV

Candida Vitale, MD, PhD

Assistant Professor
Department of Molecular Biotechnology and Health Sciences, University of Torino & University Division of Hematology, A.O.U. Città della Salute e della Scienza di Torino
Torino, Piemonte, Italy